| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.3B | $7.2B | $8.9B | $10.1B | $7.4B | $1.1B | $1.2B | $1.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.0B | $2.1B | $2.2B | $2.0B | $2.0B | $1.9B | — | — |
| Operating Income | $1.1B | $0.8B | $-1.4B | $1.7B | $2.4B | $0.1B | $-0.1B | $0.1B |
| Net Income | $0.7B | $0.3B | $-1.5B | $1.1B | $1.5B | $0.0B | $-0.1B | $0.0B |
| EPS (Basic) | $3.15 | $1.27 | $-7.16 | $5.11 | $7.02 | $0.05 | $-0.27 | $0.14 |
| EPS (Diluted) | $3.09 | $1.25 | $-7.16 | $4.97 | $6.92 | $0.05 | $-0.27 | $0.14 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.5B | $15.1B | $15.4B | $17.6B | $16.7B | $14.0B | $13.3B | $12.0B |
| Current Assets | $1.8B | $1.7B | $2.0B | $3.8B | $3.3B | $1.5B | $1.6B | $1.9B |
| Cash & Equivalents | $0.3B | $0.2B | $0.2B | $0.4B | $0.9B | $0.3B | $0.4B | $0.5B |
| Total Liabilities | $10.7B | $10.7B | $11.0B | $11.5B | $11.2B | $9.8B | $9.5B | $7.9B |
| Current Liabilities | $2.0B | $2.1B | $2.3B | $2.4B | $2.3B | $1.8B | $2.0B | $1.7B |
| Stockholders' Equity | $4.8B | $4.3B | $4.4B | $6.1B | $5.5B | $4.1B | $3.8B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.2B | $1.1B | $0.7B | $1.5B | $1.1B | $1.1B | $1.1B |
| Investing Cash Flow | $-0.7B | $-0.8B | $-1.1B | $-1.0B | $-1.1B | $-0.6B | $-2.1B | $-0.7B |
| Capital Expenditures | $0.8B | $0.8B | $1.0B | $0.8B | $0.7B | $0.7B | $0.7B | $0.6B |
| Financing Cash Flow | $-0.4B | $-0.5B | $-0.2B | $-0.1B | $0.2B | $-0.6B | $1.0B | $-0.4B |